Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Multiple Myeloma 23Recurrence 3Neoplasms, Plasma Cell 2Lymphoma 2beta-Thalassemia 1Thalassemia 1Sarcoma, Myeloid 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Plasmablastic Lymphoma 1Neoplasms 1Neoplasm Metastasis 1Multi-centric Castleman's Disease 1Macular dystrophy, corneal type 1 1Lymphoproliferative Disorders 1Lymphoma, Mantle-Cell 1Lymphadenopathy 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1HIV Infections 1Carcinoma, Non-Small-Cell Lung 1Anemia, Sickle Cell 1

Interventions

pembrolizumab 19Specimen Handling 19Biopsy 13Magnetic Resonance Spectroscopy 12Carboplatin 11Paclitaxel 10Pemetrexed 8Nivolumab 7Irinotecan 7Gemcitabine 7trastuzumab deruxtecan 6Fulvestrant 6Radiosurgery 5Leucovorin 5Fluorouracil 5Cisplatin 5Cetuximab 5Bevacizumab 5palbociclib 4durvalumab 4Taxes 4Oxaliplatin 4Letrozole 4Docetaxel 4ribociclib 3olaparib 3Trastuzumab 3Panitumumab 3Midazolam 3Ipilimumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Bortezomib × 30 days × Clear all
NCT00720785 2026-06-08

Natural Killer Cells and Bortezomib to Treat Cancer

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
35 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

Carcinoma, Non-Small-Cell Lung, Multiple Myeloma, Neoplasm Metastasis, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡